Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Nantahala Capital Management, LLC's stake in Zevra Therapeutics, Inc. fell to 4.38% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Nantahala Capital Management, LLC's stake in Zevra Therapeutics, Inc. fell to 4.38%, 2,340,333 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.38%
- Shares
- 2,340,333
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 4.38% | 2,340,333 |
| Wilmot B. Harkey | 4.38% | 2,340,333 |
| Daniel Mack | 4.38% | 2,340,333 |
Source
Related
- Zevra Therapeutics, Inc.
- Nantahala Capital Management, LLC
- Zevra Therapeutics, Inc. shareholders
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026